Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

Giasson, Benoit I., Forman, Mark S., Higuchi, Makoto, Golbe, Lawrence I., Graves, Charles L., Kotzbauer, Paul T., Trojanowski, John Q., Lee, Virginia M.-Y.·2003·Science

DOI 10.1126/science.1082324

Cited by (879)

Items 201–300 of 879

Interactions of Amyloidogenic Proteins
Benoit I. Giasson, Virginia M.‐Y. Lee, John Q. Trojanowski · 2003 · NeuroMolecular Medicine
Interneuronal Transfer of Human Tau Between Lamprey Central Neurons in situ
WonHee Kim, Sangmook Lee, Cheolwha Jung, Ambar Ahmed, Gloria S. Lee, Garth F. Hall · 2010 · Journal of Alzheimer s Disease
Protein oxidative modifications in the ageing brain: Consequence for the onset of neurodegenerative disease
Stefanie Grimm, Annika Höhn, Kelvin J.A. Davies, Tilman Grune · 2010 · Free Radical Research
Parkinsonism genes: culprits and clues
Asa Abeliovich, M. Flint Beal · 2006 · Journal of Neurochemistry
Haplotypes and gene expression implicate the MAPT region for Parkinson disease
Jennifer E. Tobin, Jeanne C. Latourelle, Mark Lew, Christine Klein, Oksana Suchowersky, Holly A. Shill, Lawrence I. Golbe, Margery H. Mark, John H. Growdon, G. Frederick Wooten et al. · 2008 · Neurology
α-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton
Alessandro Esposito, Christoph Peter Dohm, Pawel Kermer, Mathias Bähr, Fred Silvester Wouters · 2007 · Neurobiology of Disease
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
Jon B. Toledo, Ané Korff, Leslie M. J. Shaw, John Q. Trojanowski, Jing Zhang · 2013 · Acta Neuropathologica
The limbic and neocortical contribution of α‐synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies
Tanis J. Ferman, Naoya Aoki, Julia E. Crook, Melissa Erin Murray, Neill R. Graff‐Radford, Jay A. van Gerpen, Ryan J. Uitti, Zbigniew K. Wszołek, Jonathan Graff‐Radford, Otto Pedraza et al. · 2017 · Alzheimer s & Dementia
Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
Shalini S. Rao, Paul Anthony Adlard · 2018 · Frontiers in Molecular Neuroscience
Early involvement of the cerebral cortex in Parkinson's disease: Convergence of multiple metabolic defects
Isidró Ferrer · 2009 · Progress in Neurobiology
Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration
Christiane Richter‐Landsberg, Janina Leyk · 2013 · Acta Neuropathologica
Three Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau Filaments
Stephanie J. Adams, Michael A. Deture, Melinda McBride, Dennis W. Dickson, Leonard Petrucelli · 2010 · PLoS ONE
Vascular and metabolic dysfunction in Alzheimer’s disease: a review
Murray, Ian V J, Proza, Joseph F, Sohrabji, Farida, Lawler, John M · 2011 · Experimental Biology and Medicine
Multifaceted deaths orchestrated by mitochondria in neurones
Phillip Nagley, Gavin C. Higgins, Julie D. Atkin, Philip M. Beart · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Initiation of Parkinson’s disease from gut to brain by δ-secretase
Eun Hee Ahn, Seong Su Kang, Xia Liu, Guiqin Chen, Zhentao Zhang, Bindu P. Chandrasekharan, Ashfaqul M. Alam, Andrew Scott Neish, Xuebing Cao, Keqiang Ye · 2019 · Cell Research
Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
Mark A. Frasier, Mark Walzer, L. McCarthy, Debra J. Magnuson, J.M. Lee, Carola A. Haas, Philipp J. Kahle, Benjamin L. Wolozin · 2004 · Experimental Neurology
The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
Oi Wan Wan, Kenny K. K. Chung · 2012 · PLoS ONE
Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
Kawahata, Ichiro, Finkelstein, David I., Fukunaga, Kohji · 2022 · International Journal of Molecular Sciences
Parkinson's Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis
Peter G. Jenner, Huw R. Morris, Trevor William Robbins, Michel Goedert, John Hardy, Yoav Ben‐Shlomo, J. Paul Bolam, David John Burn, John Vincent Hindle, David James Brooks et al. · 2013 · Journal of Parkinson s Disease
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
Naomi P. Visanji, Anthony Edward Lang, Gábor Géza Kovács · 2019 · Translational Neurodegeneration
Molecular mechanism for the synchronized electrostatic coacervation and co-aggregation of alpha-synuclein and tau
Pablo Gracia, David Polanco, Jorge Tarancón-Díez, Ilenia Serra, Maruan Alberto Bracci, Javier Oroz, Douglas V. Laurents, Inés García‐Rubio, Nunilo Cremades · 2022 · Nature Communications
Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
Kyu Hwan Shim, Min Ju Kang, Young Chul Youn, Seong Soo A. An, SangYun Kim · 2022 · Alzheimer s Research & Therapy
Structure and Mechanism of Action of Tau Aggregation Inhibitors
Katryna K. Cisek, Grace Cooper, Carol J. Huseby, Jeff Kuret · 2014 · Current Alzheimer Research
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Xingyu Zhang, Jiangyu Wang, Zhentao Zhang, Keqiang Ye · 2024 · Translational Neurodegeneration
Aberrant Phosphorylation of α-Synuclein in Human Niemann-Pick Type C1 Disease
Yuko Saito, Kinuko Suzuki, Christine Marie Hulette, Shigeo Murayama · 2004 · Journal of Neuropathology & Experimental Neurology
α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment
Korff, Ane, Liu, Changqin, Ginghina, Carmen, Shi, Min, Zhang, Jing, for the Alzheimer's Disease Neuroimaging Initiative · 2013 · Journal of Alzheimer’s Disease
Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions
Zachary A. Sorrentino, N. Vijayaraghavan, Kimberly-Marie M. Gorion, Cara J. Riffe, Kevin H. Strang, Jason D. Caldwell, Benoit I. Giasson · 2018 · Journal of Biological Chemistry
Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations
Anvesh K. R. Dasari, Rakez Kayed, Sungsool Wi, Kwang Hun Lim · 2019 · Biochemistry
The Utility of α-Synuclein as Biofluid Marker in Neurodegenerative Diseases: a Systematic Review of The Literature
Anja Hviid Simonsen, H. Bea Kuiperij, Omar M. A. El‐Agnaf, Sebastian Engelborghs, Sanna‐Kaisa Herukka, Lucilla Parnetti, Irena Rektorová, Eugeen Vanmechelen, Elisabeth N. Kapaki, Marcel M. Verbeek et al. · 2015 · Biomarkers in Medicine
Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease
Kurt R. Brunden, John Q. Trojanowski, Amos B. Smith, Virginia M.‐Y. Lee, Carlo Ballatore · 2014 · Bioorganic & Medicinal Chemistry
Biomarkers of cognitive decline in Parkinson's disease
Chin‐Hsien Lin, Ruey‐Meei Wu · 2015 · Parkinsonism & Related Disorders
Exosomes in neurologic and psychiatric disorders
Tsilioni, Irene, Panagiotidou, Smaro, Theoharides, Theoharis C. · 2014 · Clinical Therapeutics
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Somin Kwon, Michiyo Iba, Changyoun Kim, Eliezer Masliah · 2020 · Neurotherapeutics
Relationship of phosphorylated α-synuclein and tau accumulation to Aβ deposition in the cerebral cortex of dementia with Lewy bodies
Kimiko Obi, Haruhiko Akiyama, Hiromi Kondo, Yoko Shimomura, Masato Hasegawa, Takeshi Iwatsubo, Yoshikuni Mizuno, Hideki Mochizuki · 2007 · Experimental Neurology
Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies
Hiroshige Fujishiro, Yoshio Tsuboi, Wen-Lang Lin, Hirotake Uchikado, Dennis W. Dickson · 2008 · Acta Neuropathologica
Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration
Giuseppina Amadoro, Veronica Corsetti, Anna Atlante, Fulvio Florenzano, Simona Capsoni, Rossana Bussani, Delio Mercanti, Pietro Calissano · 2011 · Neurobiology of Aging
Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
Gaetano Calabrese, Cristen M. Molzahn, Thibault Mayor · 2022 · Journal of Biological Chemistry
Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders
George Bartzokis · 2003 · Neurobiology of Aging
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
Alexis Elbaz, Owen A. Ross, John P. A. Ioannidis, Alexandra I. Soto‐Ortolaza, Frédéric Moisan, Jan Olav Aasly, Grazia Annesi, Maria Bozi, Laura Brighina, Marie‐Christine Chartier‐Harlin et al. · 2010 · Annals of Neurology
Genetic contributions to Parkinson's disease
Yue Ming Huang, Linda Cheung, Dominic B. Rowe, Glenda Margaret Halliday · 2004 · Brain Research Reviews
Nosology of Parkinson’s Disease: Looking for the Way Out of a Quackmire
Mark S. Forman, Virginia M.‐Y. Lee, John Q. Trojanowski · 2005 · Neuron
Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
A. Raquel Esteves, Daniela M. Arduíno, Diana Filipa Silva, Catarina Resende Oliveira, Sandra M. Cardoso · 2011 · Parkinson s Disease
Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease
Janelle N. Fawver, Yonatan Ghiwot, Catherine Koola, Wesley Carrera, Jennifer Rodriguez-Rivera, Caterina M. Hernandez, Kelly T. Dineley, Yu Kong, Jianrong Li, Jack H. Jhamandas et al. · 2014 · Current Alzheimer Research
The morbid anatomy of dementia in Parkinson’s disease
Michail E. Kalaitzakis, R. K. B. Pearce · 2009 · Acta Neuropathologica
Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro
Hamid Y. Qureshi, Hemant K. Paudel · 2010 · Journal of Biological Chemistry
The North American Multiple System Atrophy Study Group
Sid Gilman, Susanne J. May, Clifford W. Shults, Caroline M. Tanner, Walter A. Kukull, Virginia M.-Y. Lee, Eliezer Masliah, Phillip A. Low, Paola Sandroni, John Q. Trojanowski et al. · 2005 · Journal of Neural Transmission
Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
Francesca Longhena, Gaia Faustini, Maria Grazia Spillantini, Arianna Bellucci · 2019 · International Journal of Molecular Sciences
Prion protein (PrPc) promotes β-amyloid plaque formation
Katja Schwarze-Eicker, Kathy Keyvani, Nicole Goertz, David A. Westaway, Norbert Sachser, Werner Paulus · 2004 · Neurobiology of Aging
Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson’s disease
Fang Fang, Wanlin Yang, Jazmin B. Florio, Edward M. Rockenstein, Brian J. Spencer, Xavier Orain, Stephanie X. Dong, Huayan Li, Xu‐Qiao Chen, Kijung Sung et al. · 2017 · Scientific Reports
Pressure-dissociable reversible assembly of intrinsically denatured lysozyme is a precursor for amyloid fibrils
T.N. Niraula, Takashi Konno, Hua Li, Hiroaki Yamada, Kazuyuki Akasaka, Hideki Tachibana · 2004 · Proceedings of the National Academy of Sciences
Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
Zachary A. Sorrentino, Marshall S. Goodwin, Cara J. Riffe, Jess-Karan S. Dhillon, Yuxing Xia, Kimberly-Marie M. Gorion, N. Vijayaraghavan, Karen N. McFarland, Lawrence I. Golbe, Anthony T. Yachnis et al. · 2019 · Acta Neuropathologica Communications
The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
Dietmar Rudolf Thal, Sandra O. Tomé · 2022 · Brain Research Bulletin
α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly
Takayuki Oikawa, Takashi Nonaka, Makoto Terada, Akira Tamaoka, Shin‐ichi Hisanaga, Masato Hasegawa · 2016 · Journal of Biological Chemistry
Extracellular Vesicles for the Diagnosis and Treatment of Parkinson’s Disease
Raghavendra Upadhya, Ashok Kumar Shetty · 2021 · Aging and Disease
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Pauline Wales, Raquel Pinho, Diana F. Lázaro, Tiago F. Outeiro · 2013 · Journal of Parkinson s Disease
α-Synuclein-carrying extracellular vesicles in Parkinson’s disease: deadly transmitters
Dimitry A. Chistiakov, Alexander A. Chistiakov · 2016 · Acta Neurologica Belgica
Exosomes-associated neurodegeneration and progression of Parkinson's disease.
Isabella Russo, Luigi Bubacco, Elisa Greggio · 2012 · Europe PMC (PubMed Central)
α-Synuclein Oligomers Induce a Unique Toxic Tau Strain
Castillo-Carranza, Diana L., Guerrero-Muñoz, Marcos J., Sengupta, Urmi, Gerson, Julia E., Kayed, Rakez · 2018 · Biological Psychiatry
Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential
Nelson Ferreira, Hjalte Gram, Zachary A. Sorrentino, Emil Gregersen, Sissel Ida Schmidt, Lasse Reimer, Cristine Betzer, Clara Pérez-Gozalbo, Marjo Beltoja, Madhu Nagaraj et al. · 2021 · Acta Neuropathologica
Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs
Johannes Attems, Magdalena Quass, K. A. Jellinger · 2006 · Acta Neuropathologica
Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy
Balvindar Singh, Ana Covelo, Hector A. Martell-Martinez, Carmen Nanclares, Mathew A. Sherman, Emmanuel Okematti, Joyce P. Meints, Peter J. Teravskis, Christopher Gallardo, Alena V. Savonenko et al. · 2019 · Acta Neuropathologica
Pathogenic effects of α-synuclein aggregation
Ditte M. S. Lundvig, Evo Lindersson, Poul Henning Jensen · 2004 · Molecular Brain Research
Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation
Jinxia Lu, Shengnan Zhang, Xiaojuan Ma, Chunyu Jia, Zhenying Liu, Chengan Huang, Cong Liu, Dan Li · 2020 · Journal of Biological Chemistry
Tau and MAPT genetics in tauopathies and synucleinopathies
Etienne Léveillé, Owen A. Ross, Ziv Gan‐Or · 2021 · Parkinsonism & Related Disorders
Selective Molecular Recognition in Amyloid Growth and Transmission and Cross-Species Barriers
Buyong Ma, Ruth Nussinov · 2011 · Journal of Molecular Biology
γ-Synuclein: Seeding of α-Synuclein Aggregation and Transmission between Cells
Irina G. Surgucheva, Victor S. Sharov, Andrei P. Surguchov · 2012 · Biochemistry
Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions
Sebastian Dütting, Sebastian Brachs, Dirk Mielenz · 2011 · Cell Communication and Signaling
Enduring involvement of tau, β-amyloid, α-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism–dementia complex of Guam (ALS/PDC)
Judith Miklossy A, John C. Steele, Sheng Yuan Yu, Sherman A. McCall, Glenn D. Sandberg, Edith G. McGeer, Patrick L. McGeer · 2008 · Acta Neuropathologica
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Julia E. Gerson, Kathleen M. Farmer, Natalie Henson, Diana Laura Castillo‐Carranza, Mariana Carretero Murillo, Urmi Sengupta, Alan D.T. Barrett, Rakez Kayed · 2018 · Molecular Neurodegeneration
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
Marta Milà‐Alomà, Marc Suárez‐Calvet, José Luís Molinuevo · 2019 · Therapeutic Advances in Neurological Disorders
Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
Janett Köppen, Anja Schulze, Lisa Machner, Michael Wermann, Rico Eichentopf, Max Guthardt, Angelika Hähnel, Jessica Klehm, Marie-Christin Kriegeskorte, Maike Hartlage‐Rübsamen et al. · 2020 · Molecules
Interaction of 14-3-3ζ with Microtubule-Associated Protein Tau within Alzheimer’s Disease Neurofibrillary Tangles
Hamid Y. Qureshi, Tong Li, Ryen MacDonald, Chulmin Cho, Nicole M. Leclerc, Hemant K. Paudel · 2013 · Biochemistry
Regional Overlap of Pathologies in Lewy Body Disorders
Martí Colom‐Cadena, Oriol Grau‐Rivera, Lluís Planellás, Catalina Cerquera‐Cleves, Estrella Morenas‐Rodríguez, Sergio Helgueta, Laia Muñoz, Jaime Kulisevsky, Marı́a José Martı́, Eduard S. Tolosa et al. · 2017 · Journal of Neuropathology & Experimental Neurology
Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism
Paramita Chaudhuri, Kailash Prasad Prajapati, Bibin Gnanadhason Anand, Kriti Dubey, Karunakar Kar · 2019 · Ageing Research Reviews
Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study
K. A. Jellinger · 2007 · Springer eBooks
Conformational Prerequisites for Formation of Amyloid Fibrils from Histones
Larissa A. Munishkina, Anthony L. Fink, Vladimir Nikolaevich Uversky · 2004 · Journal of Molecular Biology
MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy
Carles Vilariño‐Güell, Alexandra I. Soto‐Ortolaza, Alex H. Rajput, Deborah C. Mash, Spyridon Papapetropoulos, Rajesh Pahwa, Kelly E. Lyons, Ryan J. Uitti, Zbigniew K. Wszołek, Dennis W. Dickson et al. · 2011 · Neurology
Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease
Roy, Bidisha, Jackson, George R. · 2014 · Human Molecular Genetics
PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins
Alexandra Pérez‐Soriano, Julieta Arena, Katie Dinelle, Qing Miao, Jessamyn McKenzie, Nicole Neilson, Andreas Puschmann, Paul C. Schaffer, Hitoshi Shinotoh, Jenna Smith‐Forrester et al. · 2017 · Movement Disorders
Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis
Hallie I. Geller, Avinainder Singh, Tara M. Mirto, Robert F. Padera, Richard N. Mitchell, Jacob P. Laubach, Rodney H. Falk · 2017 · Mayo Clinic Proceedings
Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the α-synuclein gene
Keiji Yamaguchi, Elizabeth J. Cochran, Jill R. Murrell, Mihael H. Polymeropoulos, Kathleen M. Shannon, R. Anthony Crowther, Michel Goedert, Bernardino Francesco Ghetti · 2005 · Acta Neuropathologica
Comparing Cerebral Perfusion in Alzheimer's Disease and Parkinson's Disease Dementia: An ASL-MRI Study
Campbell J. Le Heron, Sarah L Wright, Tracy R. Melzer, Daniel J. Myall, Michael R. MacAskill, Leslie Livingston, Ross J. Keenan, Richard Watts, John C. Dalrymple‐Alford, Tim Anderson · 2014 · Journal of Cerebral Blood Flow & Metabolism
Potential mechanisms and implications for the formation of tau oligomeric strains
Julia E. Gerson, Amritpal K. Mudher, Rakez Kayed · 2016 · Critical Reviews in Biochemistry and Molecular Biology
Characterization of tau fibrillization in vitro
Shaohua Xu, Kurt R. Brunden, John Q. Trojanowski, Virginia M.‐Y. Lee · 2010 · Alzheimer s & Dementia
The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
Ciccone, Lidia, Shi, Chenghui, di Lorenzo, Davide, Van Baelen, Anne-Cécile, Tonali, Nicolo · 2020 · Molecules
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy
Kundlik Gadhave, Deepak Kumar, Vladimir Nikolaevich Uversky, Rajanish Giri · 2020 · Medicinal Research Reviews
Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers
Félix Hernández, Raquel Cuadros, Jesús Ávila · 2004 · Neuroscience Letters
Proteins Recruited to Exosomes by Tau Overexpression Implicate Novel Cellular Mechanisms Linking Tau Secretion with Alzheimer's Disease
Sudad Saman, Norman C.Y. Lee, Itoro E. Inoyo, Jun Jin, Zhihan Li, Thomas Doyle, Ann Carolyn McKee, Garth F. Hall · 2014 · Journal of Alzheimer s Disease
Distinct patterns of amyloid‐dependent tau accumulation in Lewy body diseases
Seung Ha Lee, Hanna Cho, Jae Yong Choi, Jae‐Hoon Lee, Young Hoon Ryu, Myung Sik Lee, Chul Hyoung Lyoo · 2017 · Movement Disorders
Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level
Georg Nübling, Benedikt Bader, Johannes Levin, Jenna Hildebrandt, Hans A. Kretzschmar, Armin Giese · 2012 · Molecular Neurodegeneration
Tau phosphorylation and proteolysis: Insights and perspectives
Gail V.W. Johnson · 2006 · Journal of Alzheimer s Disease
Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease
Patricia Mugure Chege, Gawain McColl · 2014 · Frontiers in Aging Neuroscience
Nervous yeast: modeling neurotoxic cell death
Ralf J. Braun, Sabrina Büttner, Julia Ring, Guido Kroemer, Frank Madeo · 2009 · Trends in Biochemical Sciences
The gene expression profile of extraskeletal myxoid chondrosarcoma
Subbaya Subramanian, Robert B. West, Robert J. Marinelli, Torsten O. Nielsen, Brian P. Rubin, John R. Goldblum, Rajiv M. Patel, Shirley Zhu, Kelli D. Montgomery, Tony Ng et al. · 2005 · The Journal of Pathology
Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease
Jana Vandrovcová, Alan Michael Pittman, Elke Malzer, Patrick M. Abou‐Sleiman, Andrew John Lees, Nicholas William Wood, Rohan de Silva · 2008 · Neurobiology of Aging
Disorders of synaptic vesicle fusion machinery
Holly Melland, Elyas H. Arvell, Sarah L. Gordon · 2020 · Journal of Neurochemistry
Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease
Marcos Jair Guerrero‐Munoz, Diana Laura Castillo‐Carranza, Shashirekha Krishnamurthy, Adriana A. Paulucci-Holthauzen, Urmi Sengupta, Cristian A. Lasagna‐Reeves, Yembur Ahmad, George R. Jackson, Rakez Kayed · 2014 · Neurobiology of Disease
Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat
Robert J. Phillips, Gary C. Walter, Brittany E. Ringer, Katherine M. Higgs, Terry L. Powley · 2009 · Experimental Neurology
Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease Process
Hirotake Uchikado, Anthony DelleDonne, Zeshan Ahmed, Dennis W. Dickson · 2006 · Journal of Neuropathology & Experimental Neurology
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
Denis Ottolini, Tito Calí, Ildikò Szabó, Marisa Brini · 2016 · Biological Chemistry